rs6897932 — IL7R T244I

IL7R T244I — The Soluble Receptor Switch That Tips T-Cell Balance

Interleukin-7 (IL-7) is an indispensable cytokine for T-cell development and homeostasis. Without adequate IL-7 signaling, the thymus cannot export naïve T cells¹¹ thymus cannot export naïve T cells
IL-7 promotes survival and proliferation of naïve and memory T cells; deficiency causes lymphopenia and failure of T-cell development and the peripheral T-cell pool shrinks. IL-7 acts through its receptor, IL-7Rα (CD127), encoded by the IL7R gene on chromosome 5. The T244I variant — rs6897932 — sits in exon 6 of IL7R, the exon that encodes the transmembrane anchor of the receptor. What looks like a simple amino acid change is actually a splicing switch: the C allele at this position increases the likelihood that exon 6 will be skipped during mRNA processing, producing a soluble secreted form of the receptor (sIL7R) rather than the membrane- bound form. This shift in the membrane-to-soluble ratio has consequences for T-cell regulation and confers one of the most consistently replicated autoimmune risk signals²² one of the most consistently replicated autoimmune risk signals
IL7R was among the first confirmed non-MHC MS loci; confirmed across four independent datasets with p=2.9×10⁻⁷ in the original 2007 paper outside the MHC.

The Mechanism

Exon 6 of IL7R encodes the transmembrane domain. When exon 6 is included in the mRNA, the resulting protein anchors to the T-cell surface as membrane-bound IL-7Rα. When exon 6 is skipped, the reading frame shifts to produce a soluble secreted isoform (sIL7R) that circulates in the bloodstream. Healthy individuals produce both forms, but the ratio is tightly controlled.

The C allele at rs6897932 tips this balance toward exon skipping. Mechanistically, the C allele strengthens a cryptic branch-point sequence within exon 6³³ the C allele strengthens a cryptic branch-point sequence within exon 6
The BPS is followed by a polypyrimidine tract that recruits U2AF2 ectopically into the exon body rather than its canonical intronic location. U2AF2 binding to this exonic polypyrimidine tract assembles a silencing complex that promotes exon 6 exclusion from the mature transcript. The result: C-allele carriers produce a higher fraction of sIL7R and a lower fraction of membrane-bound receptor. In stimulated monocytes, CC homozygotes generate markedly more sIL7R than TT carriers⁴⁴ markedly more sIL7R than TT carriers
Strong allele-dose-dependent effect on sIL7R secretion observed after LPS stimulation in monocytes from CC, CT, and TT donors.

Why does elevated sIL7R raise autoimmune risk? Circulating sIL7R forms complexes with IL-7, and rather than blocking IL-7 activity, these complexes potentiate IL-7's half-life and bioavailability⁵⁵ potentiate IL-7's half-life and bioavailability
IL-7/sIL7R complexes are more stable than free IL-7, extending its functional lifespan in circulation and amplifying homeostatic T-cell signaling. More available IL-7 drives increased T-cell survival and proliferation, expanding the T-cell pool in a way that can include self-reactive clones. Mouse models confirm the consequence: exogenous sIL7R exacerbates disease in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.

The Evidence

The MS association was first established by Gregory et al. in 2007⁶⁶ Gregory et al. in 2007
Analysis of four independent datasets totaling >3,000 cases; overall P = 2.9 × 10⁻⁷, making IL7R one of the first confirmed non-MHC MS risk loci. Two large meta-analyses have since quantified the effect: one covering 28 studies with 16,260 MS cases and 18,335 controls⁷⁷ 28 studies with 16,260 MS cases and 18,335 controls
Pooled ORs: allelic 1.11, dominant 1.17, recessive 1.13; effect strongest in European populations, not replicated in Middle Eastern cohorts, and a second covering 33 case-control studies with 19,351 patients⁸⁸ 33 case-control studies with 19,351 patients
T allele protective in Europeans; recessive model OR=0.84, allelic OR=0.91, TT vs CC OR=0.79 confirming the T allele's protective effect. The association is primarily established in European populations; Middle Eastern and Asian cohorts have shown weaker or no significant association, consistent with the substantially higher C allele frequency in those populations (83–89% vs ~74% in Europeans).

Beyond MS, the same rs6897932 locus has been associated with ankylosing spondylitis, primary biliary cirrhosis, systemic lupus erythematosus, and inflammatory bowel disease⁹⁹ ankylosing spondylitis, primary biliary cirrhosis, systemic lupus erythematosus, and inflammatory bowel disease
Consistent with a shared immune dysregulation mechanism involving elevated sIL7R and altered T-cell homeostasis. For early-onset type 1 diabetes, an independent replication study in Spanish and Dutch cohorts¹⁰¹⁰ an independent replication study in Spanish and Dutch cohorts
TT genotype OR 0.18 for early-onset T1D (p = 0.02); protective effect seen in both cohorts independently found that TT homozygosity was strongly protective, suggesting the T allele's protection extends across T-cell-mediated autoimmune diseases broadly.

Vitamin D status is an established environmental modifier of MS risk. Prospective studies consistently show that lower serum 25-OH vitamin D is associated with higher MS incidence; this environmental risk operates alongside genetic risk factors including IL7R genotype.

Interactions

The closest documented genetic interaction involves rs2523506 in DDX39B. DDX39B encodes an RNA helicase that promotes IL7R exon 6 inclusion — the functional opposite of what the IL7R C allele does. A landmark Cell 2017 study¹¹¹¹ Cell 2017 study
Epistatic interaction between rs2523506 and rs6897932; combined risk homozygotes (IL7R CC, DDX39B AA) show OR=2.75 (95% CI 1.86–4.08; p=4.5×10⁻⁷) — far exceeding either alone demonstrated that the A allele at DDX39B rs2523506 reduces DDX39B protein levels (via impaired mRNA translation), removing the protective exon 6 inclusion that DDX39B normally provides. When both risk homozygotes coincide, the combined MS odds ratio reaches 2.75 — one of the clearest demonstrations of biological epistasis in human complex disease.

A second independent interaction exists with rs2104286 in IL2RA (the interleukin-2 receptor alpha chain, CD25). Both IL7R and IL2RA are essential T-cell homeostatic signaling components, and both contain well-replicated MS susceptibility variants. The two variants have independent additive effects — carriers of risk alleles at both loci have compounded MS susceptibility reflecting disruption of complementary T-cell regulatory pathways.